Automated insulin delivery for type 1 diabetes study
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 7 years old (if a child) or 18 years old (if an adult).
- You must have had type 1 diabetes for at least 6 months (children) or 3 years (adults).
- You must have used a continuous glucose monitor (CGM) for at least 6 months.
- Your doctor must approve you starting an automated insulin delivery (AID) system for this study.
- You cannot be using certain other medicines (like steroids or non-insulin diabetes drugs), have severe heart disease, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This study is testing whether an automated insulin delivery system (often called an artificial pancreas) can help adults who have just been diagnosed with type 1 diabetes manage their blood sugar levels. It aims to improve long-term control and make day-to-day management easier.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests whether starting an automated insulin delivery (AID) system soon after a type 1 diabetes diagnosis helps improve blood sugar control and reduces future health problems. The AID system combines a pump and continuous glucose monitor to automatically adjust insulin.
This study tests an artificial intelligence feature that helps the insulin pump deliver extra insulin before meals. It aims to improve blood sugar control for adults with type 1 diabetes who already use an automated insulin delivery system.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.